论文部分内容阅读
目的:观察孟鲁司特钠联合酮替芬治疗小儿支气管炎的临床效果,为其临床应用价值提供科学依据。方法:研究对象取自于我院收治的56例支气管炎患儿,随机将患儿均分为对照组与观察组。对照组患儿单纯使用孟鲁司特钠进行治疗;观察组患儿使用孟鲁司特钠联合酮替芬进行治疗。结果:对照组与观察组患儿治疗总有效率分别为:71.4%和92.9%,相较于对照组,观察组患儿治疗效果明显更佳,两组对比差异显著(P<0.05)。结论:孟鲁司特钠联合酮替芬治疗小儿支气管炎效果显著,适合于临床推广应用。
Objective: To observe the clinical efficacy of montelukate combined with ketotifen in the treatment of pediatric bronchitis, and provide a scientific basis for its clinical value. Methods: The subjects were from 56 cases of bronchitis admitted to our hospital. The children were randomly divided into control group and observation group. Patients in the control group were treated with montelukast sodium alone; patients in the observation group were treated with montelukast sodium and ketotifen. Results: The total effective rate in the control group and the observation group was 71.4% and 92.9% respectively. Compared with the control group, the therapeutic effect of the observation group was significantly better, and the difference was significant (P <0.05). Conclusion: Montelukast combined with ketotifen treatment of children with bronchitis significant effect, suitable for clinical application.